# Biomarkers for Prognosis of Glioblastoma (GBM)

> **NCT01493219** · — · COMPLETED · sponsor: **University of Nebraska** · enrollment: 19 (actual)

## Conditions studied

- Glioblastoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01493219
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-20
- **Primary completion:** 2017-09-01
- **Final completion:** 2017-09-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01493219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01493219, "Biomarkers for Prognosis of Glioblastoma (GBM)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01493219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*